共 98 条
- [1] Goeree R(1996)An assessment of the burdenof illness due to osteoporosis in Canada Journal SOGC 7 15-24
- [2] O’Brien B(1996)Canadian guidelinesfor economic evaluation of pharmaceuticals Pharmacoeconomics 9 535-59
- [3] Pettit D(1997)The economics of osteoporosis andits prevention, a review Pharmacoeconomics 11 126-38
- [4] Torrance GW(1996)Canadian Database of Osteoporosis and Osteopenia Patients (CANDOO) Can Organ Adv Comput Healthcare Proc 21 41-4
- [5] Blaker D(1995)The VAMP research multi-purpose databasein the U.K J Clin Epidemiol 48 431-43
- [6] Detsky A(1995)Meta-analysis tools for medicaldecision making: a practical guide Med Decis Making 15 81-96
- [7] Torgerson DJ(1994)Effects of calciumsupplements on femoral bone mineral density and vertebralfracture rate in vitamin-D-replete elderly patients Osteoporos Int 4 245-52
- [8] Reid DM(1992)Treatment ofpostmenopausal osteoporosis with transdermal estrogen Ann Intern Med 117 1-9
- [9] Sebaldt RJ(1986)Long-term fluoridetherapy of postmenopausal osteoporosis Bone 7 199-205
- [10] Adachi JD(1994)Hormone replacement therapy II: apharmacoeconomic appraisal of its role in the prevention ofpostmenopausal osteoporosis and ischaemic heart disease Pharmacoeconomics 5 513-54